Letter: Parasagittal/Falcine Tumor Location Strongly Predicts Human Telomerase Reverse Transcriptase Promoter Mutations in High-Grade Meningiomas

被引：6

作者：

Peetz-Dienhart, Susanne ^{[1
]}

Spille, Dorothee Caecilia ^{[2
]}

Sporns, Peter B. ^{[3
]}

Adeli, Alborz ^{[3
]}

Bunk, Eva Christine ^{[2
]}

Wagner, Andrea ^{[1
]}

Paulus, Werner ^{[1
]}

Stummer, Walter ^{[2
]}

Hess, Katharina ^{[1
]}

Brokinkel, Benjamin ^{[2
]}

机构：

[1] Univ Hosp Munster North Rhine Westphalia, Inst Neuropathol, Munster, Germany

[2] Univ Hosp Munster North Rhine Westphalia, Dept Neurosurg, Munster, Germany

[3] Univ Hosp Munster North Rhine Westphalia, Inst Clin Radiol, Munster, Germany

来源：

NEUROSURGERY | 2020年 / 86卷 / 03期

关键词：

D O I：

10.1093/neuros/nyz474

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：E362 / E365

页数：4

共 50 条

[41] Transgene expression of α tumor necrosis factor with mutations D142N and A144R under control of human telomerase reverse transcriptase promoter eradicates well-established tumors and induces long-term antitumor immunity
Xiang, J.
Munegowda, M. A.
Deng, Y.
CANCER GENE THERAPY, 2009, 16 (05) : 430 - 438
[42] Adenovirus-mediated and tumor-specific transgene expression of the sodium-iodide symporter from the human telomerase reverse transcriptase promoter enhances killing of lung cancer cell line in vitro
Shi Yi-zhen
Zhang Jun
Liu Zeng-li
Du Shou-ying
Shen Yong-mei
CHINESE MEDICAL JOURNAL, 2010, 123 (15) : 2070 - 2076
[43] Adenovirus-mediated and tumor-specific transgene expression of the sodium-iodide symporter from the human telomerase reverse transcriptase promoter enhances killing of lung cancer cell line in vitro
SHI Yizhen ZHANG Jun LIU Zengli DU Shouying and SHEN Yongmei Department of Nuclear Medicine the Second Affiliated Hospital of Soochow University Suzhou Jiangsu China Department of Nuclear Medicine Taizhou Peoples Hospital Taizhou Jiangsu China Department of Pathology University of California at San Diego Medical Center West Arbor Drive San Diego CA USA
中华医学杂志（英文版）, 2010, (15) : 2070 - 2076
[44] Gene therapy of pancreatic cancer with green fluorescent protein and tumor necrosis factor-related apoptosis-inducing ligand fusion gene expression driven by a human telomerase reverse transcriptase promoter
Katz, MH
Spivack, DE
Takimoto, S
Fang, BL
Burton, DW
Moossa, AR
Hoffman, RM
Bouvet, M
ANNALS OF SURGICAL ONCOLOGY, 2003, 10 (07) : 762 - 772
[45] Fiber-modified adenoviral vector expressing the tumor necrosis factor-related apoptosis-inducing ligand gene from the human telomerase reverse transcriptase promoter induces apoptosis in human hepatocellular carcinoma cells
Jacob, Dietmar
Schumacher, Guido
Bahra, Marcus
Davis, John
Zhu, Hong-Bo
Zhang, Li-Dong
Teraishi, Fuminori
Neuhaus, Peter
Fang, Bing-Liang
WORLD JOURNAL OF GASTROENTEROLOGY, 2005, 11 (17) : 2552 - 2556
[46] Fiber-modified adenoviral vector expressing the tumor necrosis factor-related apoptosis-inducing ligand gene from the human telomerase reverse transcriptase promoter induces apoptosis in human hepatocellular carcinoma cells
Dietmar Jacob
Guido Schumacher
Marcus Bahra
John Davis
Fuminori Teraishi
Peter Neuhaus
World Journal of Gastroenterology, 2005, (17) : 2552 - 2556
[47] Enforced expression of a truncated form of Bax-α (tBax) driven by human telomerase reverse transcriptase (hTERT) promoter sensitizes tumor cells to chemotherapeutic agents or tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)
Toyota, H
Kondo, S
Kyo, S
Mizuguchi, J
ANTICANCER RESEARCH, 2006, 26 (1A) : 99 - 105
[48] Targeted expression of green fluorescent protein/tumor necrosis factor-related apoptosis-inducing ligand fusion protein from human telomerase reverse transcriptase promoter elicits antitumor activity without toxic effects on primary human hepatocytes
Lin, TY
Gu, J
Zhang, LD
Huang, XF
Stephens, LC
Curley, SA
Fang, BL
CANCER RESEARCH, 2002, 62 (13) : 3620 - 3625
[49] Low-dose etoposide enhances tumor-specific adenovirus-mediated cytosine deaminase gene therapy through induction of integrin αvβ3 and αvβ5 overexpression and upregulation of human telomerase reverse transcriptase promoter
Shieh, GS
Tzai, TS
Yo, YT
Shiau, AL
Wu, CL
MOLECULAR THERAPY, 2004, 9 : S226 - S227
[50] Re: Yves Allorya, Willemien Beukers, Ana Sagrera, et al. Telomerase Reverse Transcriptase Promoter Mutations in Bladder Cancer: High Frequency Across Stages, Detection in Urine, and Lack of Association with Outcome. Eur Urol 2014;65:360-6 Telomerase Expression and Stem Cells: Urologic Epithelial Perspective
Rane, Jayant K.
Simms, Matthew S.
Maitland, Norman J.
EUROPEAN UROLOGY, 2014, 65 (06) : E85 - E86

← 1 2 3 4 5 →